# Lowry Caudill, Angel Investor

Investor in Durham, North Carolina

## About Lowry Caudill, Angel Investor

Lowry Caudill is an Entrepreneur, Investor, and Pharmaceutical Professional.

Lowry Caudill is the retired, worldwide President of Pharmaceutical Development for Cardinal Health. The Pharmaceutical Development business unit provided complete development services for the pharmaceutical industry. Caudill led over 1400 employees in nine sites including RTP, San Diego, Somerset NJ, Philadelphia, Manchester UK, and Schorndorf GER. In April 2002, Cardinal Health acquired Magellan Laboratories Incorporated, a pharmaceutical development company that Caudill and Alfred Childers co-founded in 1991.

Caudill is an active entrepreneur and supporter of entrepreneurial endeavors. He serves on the Advisory Board of Southern Capitol Ventures, serves on the Life Sciences Advisory Board of the Aurora Funds, and is a member of the Tri-State Investment Group. He is an investor and member of the Board of Directors of Liquidia Technologies Incorporated. He is a former board member and investor in Knowledge Vector, Piedmont Pharmaceuticals, and Aldagen Inc.

## People

- **Lowry Caudill**, Angel Investor

## Key Facts

- **Location:** Durham, North Carolina
- **Investor Type:** Angel Investor

## Investment Industries

- Medical/Healthcare
- Technology/Web/App
- Other

## How to Contact

Direct messaging, this investor's website, and their X profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/lowry-caudill-angel-investor
- More investors: [Medical Investors in North Carolina](https://askforfunding.com/site/angel-investors/north-carolina/medical)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
